e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Cardiovascular consequences of OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Erythrocyte deformability and plasma viscosity in obstructive sleep apnea syndrome
B. Ciftci, S. Firat Guven, N. Dikmenoglu, E. Ileri, N. Seringec (Ankara, Turkey)
Source:
Annual Congress 2005 - Cardiovascular consequences of OSA
Session:
Cardiovascular consequences of OSA
Session type:
Poster Discussion
Number:
372
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Ciftci, S. Firat Guven, N. Dikmenoglu, E. Ileri, N. Seringec (Ankara, Turkey). Erythrocyte deformability and plasma viscosity in obstructive sleep apnea syndrome. Eur Respir J 2005; 26: Suppl. 49, 372
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
PERIPHERAL ARTERIAL TONOMETRY AND INTIMA MEDIA THICKNESS IN OBSTRUCTIVE SLEEP APNEA.
Related content which might interest you:
Erythrocyte production in obstructive sleep apnea
Source: Eur Respir J 2004; 24: Suppl. 48, 692s
Year: 2004
Mean platelet volume in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease
Year: 2010
Erythrocyte glycolysis in severe obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 354s
Year: 2005
Mean platelet volume in patients with obstructive sleep apnea syndrome and its relationship with cardiovasculer diseases
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011
The importance of RDW in obstructive sleep apnea syndrome.
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018
C-reactive protein levels in obstructive sleep apnea syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 356s
Year: 2005
Serum fibrinogen in patients with obstructive sleep apnea
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020
The relationship between uric acid levels and mean platelet volume and metabolic syndrome in males with with obstructive sleep apnoea syndrome
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012
Bicarbonate venous blood level in obstructive sleep apnea syndrome: Any correlation with nocturnal hypoxia?
Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea
Year: 2021
The relationship between hypoxemia and ambulatory blood pressure in obstructive sleep apnea-hypopnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 592s
Year: 2007
Circadian rhythm of systemic blood pressure in men with obstructive sleep apnoea syndrome ( OSAS )
Source: Eur Respir J 2001; 18: Suppl. 33, 89s
Year: 2001
Circulating microparticles and endothelial dysfunction in obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008
Plasma orexin-A levels in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009
Endothelial function in obstructive sleep apnea syndrome
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
Effects of treatments with nCPAP on cerebral blood flow velocity in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
Peculiarities of GABA levels in plasma and urine of asthma patients with obstructive sleep apnea
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020
Mean platelet volume and platelet distribution width in patients with obstructive sleep apnea syndrome and chronic obstructive pulmonary disease (overlap syndrome)
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Elevated c-reactive protein in patients with obstructive sleep apnea hypopnea syndrome (OSAH)
Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea
Year: 2007
Impact of obstructive sleep apnoea and intermittent hypoxia on blood rheology: a translational study
Source: Eur Respir J, 58 (4) 2100352; 10.1183/13993003.00352-2021
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept